The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
530697-BOM Key Metrics
530697-BOM Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
530697-BOM Share Price
530697-BOM
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
530697-BOM Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Negative
Expensive and at a premium to industry median P/E
Low but stable ROE
Low but stable operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
Stock in GSM list
The stock has been places in Graded Surveillance Measure (GSM) list (GSM - 0).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0252427.
Snapshot
See detailed analysis
530697-BOM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
530697-BOM Bulk, Block & Insider Trades
530697-BOM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Bonus(1 new shares for 20 existing shares) Ex-date: 11th Oct 2018 Announced on: 25th Aug 2018
Company Profile
Zenlabs Ethica Limited is an India-based pharmaceutical contract manufacturing company. The Company develops, markets and exports a range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-bacterial Drugs, Nutraceuticals, and ... Read More
Key personnel
Mr. Sanjeev KumarD
Chairman of the Board, Managing Director
Mr. Adarsh Sharma
Chief Financial Officer
Him JyotiD
Additional Director
Mr. Harpreet Singh KalraD
Additional Non-Executive Independent Director
Mr. Anurag MalhotraD
Additional Non-Executive Independent Director
Mr. Kuldeep SinghD
Additional Non-Executive Independent Director
Narang SinghD
Non-Executive Independent Director
Narang SinghD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Zenlabs Ethica Ltd.?
The current share price of Zenlabs Ethica Ltd. is ₹ 21.57 as of 09 Jan 2026.
What is the PE ratio of Zenlabs Ethica Ltd.?
The Price-to-Earnings (PE) ratio of Zenlabs Ethica Ltd. is 56.94 as of the latest financial data.
What is the ROE and ROCE of Zenlabs Ethica Ltd.?
Zenlabs Ethica Ltd. has a Return on Equity (ROE) of 2.37% and a Return on Capital Employed (ROCE) of 5.99% as per the latest financial reports.
What is the market cap of Zenlabs Ethica Ltd.?
The market capitalization of Zenlabs Ethica Ltd. stands at ₹ 14.04 Cr.
What is the dividend yield of Zenlabs Ethica Ltd.?
The dividend yield of Zenlabs Ethica Ltd. is 0.00% based on the current market price.
What is the RSI of Zenlabs Ethica Ltd.?
The Relative Strength Index (RSI) of Zenlabs Ethica Ltd. is 47.30.
What is the FII and DII holding in Zenlabs Ethica Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Zenlabs Ethica Ltd. shares.
What sector does Zenlabs Ethica Ltd. belong to?
Zenlabs Ethica Ltd. operates in the Services sector.
What is the beta of Zenlabs Ethica Ltd. stock?
The beta of Zenlabs Ethica Ltd. stock is 0.81, indicating its volatility relative to the broader market.
